As defined by the American College of Rheumatology (ACR), OA is a heterogeneous group of condition that leads to joint signs and symptoms which are associated with defective integrity of articular cartilage, in addition to related changes in the underlying bone at the joint margins.

Non-steroidal anti-arthritis drugs (NSAIDs) are among the most generally used drugs and their widespread use is associated with increased gastrointestinal toxic effects such as ulceration, hemorrhage, perforation. They result in these complications mainly by reducing cytoprotective prostaglandins (PGE2 and PGI2) in the stomach, through the inhibition of cyclo-oxygenase (COX) enzyme.

Goniflex is proprietary formulation without any side effects as shown by NSAIDs.

Biotechnologically processed ingredients of Goniflex provide anti-inflammatory activity and significantly reduce CRP levels  to provide relief from pain and greater flexibility of joints. 

Ingredients of Goniflex also provide carbohydrates, proteins, vitamins, minerals, etc as nutritional support for joints and bones.